BioMarin Pharmaceutical has struck a deal to purchase fellow biotechnology firm Amicus Therapeutics for about $4.8 billion in money.
Source link
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
Related Posts
John Solly Is the DOGE Operative Accused of Planning to Take Social Security Data to His New Job
John Solly, a software program engineer and former member of the so-called Department of Government Efficiency (DOGE), is the DOGE…
Google I/O 2026 Signals an Extinction Event for Standalone Apps
Google I/O 2026 revealed a much more aggressive AI technique than many anticipated. Rob Enderle explains what this might imply…
4 People Indicted in Alleged Conspiracy to Smuggle Supercomputers and Nvidia Chips to China
Stern stated textual content messages obtained by authorities present Li boasting about how his father “had engaged in comparable enterprise…